A Pilot Study Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia in Clinical Routine
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2018
Price : $35 *
At a glance
- Drugs Alirocumab (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms ALIROCKS study
- 27 Jul 2018 Last checked against ClinicalTrials.gov record.
- 19 Jul 2018 Status changed from not yet recruiting to recruiting.
- 18 May 2018 New trial record